Enterprise Intelligence LARVOL’s AI-powered market intelligence aggregates insights from a broad range of sources to support large pharma and biotech partners. There is an opportunity to upsell enterprise licenses that bundle KOL monitoring, real-time news, biomarker databases, and conference planning across multiple therapeutic areas for global R&D teams.

KOL & Conferences Its strength in KOL monitoring and conference coverage can be leveraged to sell end-to-end medical affairs and events intelligence to CROs and pharma marketing teams, potentially bundling with Veri/Omni for workflow integration.

Oncology Focus With a specialized focus on oncology and access to a cancer biomarker database, LARVOL is well positioned to win business from oncology-focused assets requiring trial design support, biomarker-informed patient stratification, and competitive intelligence on competitor programs.

Global Collaboration A global team and collaboration-friendly tech stack enable serving multinational drug developers seeking regionally relevant data; offer regionally sourced data and integration with clients’ data warehouses to streamline decision-making across geographies.

SaaS Partnerships Recent SaaS offerings Veri and Omni present cross-sell opportunities for mid-market pharma and biotech; propose tiered subscriptions or bundled packages that add decision support and competitive intelligence to existing client footprints.